Albireo Pharma Stock Target Price and Analyst Consensus

ALBO
 Stock
  

USD 23.78  0.84  3.66%   

The current analyst and expert consensus on Albireo Pharma is Strong Buy, with 5 strong buy opinions. The current projected Albireo Pharma target price consensus is 75.8 with 5 analyst opinions. The most common way Albireo Pharma analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Albireo Pharma executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Albireo Pharma. We strongly encourage you to use your own analysis of Albireo Pharma to validate this buy or sell advice. Albireo Pharma buy-or-sell recommendation module provides average expert sentiment on the projected Albireo Pharma target price to derive its highest and lowest estimates based on projected price volatility of 7.758. Please continue to Macroaxis Advice on Albireo Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Gross Profit is expected to rise to about 42.3 M this year, although the value of Profit Margin will most likely fall to (81.43) . Albireo Pharma Cash and Equivalents is quite stable at the moment as compared to the past year. The company's current value of Cash and Equivalents is estimated at 267.69 Million. Shareholders Equity is expected to rise to about 189.5 M this year, although the value of Accumulated Other Comprehensive Income will most likely fall to about 974.9 K.

Albireo Pharma Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Albireo target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Albireo target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions5
Lowered Outlook0
Raized Outlook0
Strong Buy
Most Albireo analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Albireo stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Albireo Pharma, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Albireo Pharma Target Price Projection

Albireo Pharma's current and average target prices are 23.78 and 75.80, respectively. The current price of Albireo Pharma is the price at which Albireo Pharma is currently trading. On the other hand, Albireo Pharma's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Albireo Pharma Market Quote on 5th of December 2022

Low Price22.45Odds
High Price23.99Odds

23.78

Target Price

Analyst Consensus On Albireo Pharma Target Price

Low Estimate67.0Odds
High Estimate84.0Odds
Number of Analysts5
Standard Deviation7.758

75.8

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Albireo Pharma and the information provided on this page.

Albireo Pharma Analyst Ratings

Albireo Pharma's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Albireo Pharma stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Albireo Pharma's financials, market performance, and future outlook by experienced professionals. Albireo Pharma's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Albireo Pharma Target Price Projections

Albireo Pharma's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Albireo Pharma and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Albireo depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Albireo Pharma including analysis of its current option contracts.
Albireo Pharma's latest option contracts expiring on 2022-12-16 are carrying combined implied volatility of 63.13 with a put-to-call open interest ratio of 0.06 over 16 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-12-16. The current put volume is at 0, with calls trading at the volume of 89. This yields a 0.0 put-to-call volume ratio. The Albireo Pharma option chain provides detailed quote and price information for the current Albireo Pharma option contracts. It shows all of Albireo Pharma's listed puts, calls, expiration dates, strike prices, and other pricing information.
Albireo Pharma's stock options are financial instruments that give investors the right to buy or sell shares of Albireo Pharma common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Albireo stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Albireo Pharma's stock price goes up or down, the stock options follow.
Please continue to Macroaxis Advice on Albireo Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Albireo Pharma In The Money Call Balance

When Albireo Pharma's strike price is surpassing the current stock price, the option contract against Albireo Pharma stock is said to be in the money. When it comes to buying Albireo Pharma's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Albireo Pharma are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Albireo Current Options Market Mood

Albireo Pharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Albireo Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Albireo Pharma's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Albireo Pharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Albireo Pharma's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Albireo Pharma Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Albireo Pharma is a key component of Albireo Pharma valuation and have some predictive power on the future returns of a Albireo Pharma.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Albireo Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Albireo Pharma in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
17.7122.4827.25
Details
Intrinsic
Valuation
LowReal ValueHigh
21.4036.2941.06
Details
Earnings
Estimates (4)
LowProjected EPSHigh
-6.72-5.57-3.13
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Albireo Pharma. Your research has to be compared to or analyzed against Albireo Pharma's peers to derive any actionable benefits. When done correctly, Albireo Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Albireo Pharma.

Additional Albireo Pharma Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Albireo Pharma is a key component of Albireo Pharma valuation and have some predictive power on the future returns of a Albireo Pharma.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Albireo Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Albireo Pharma in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
17.7122.4827.25
Details
Intrinsic
Valuation
LowReal ValueHigh
21.4036.2941.06
Details
Earnings
Estimates (4)
LowProjected EPSHigh
-6.72-5.57-3.13
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Albireo Pharma. Your research has to be compared to or analyzed against Albireo Pharma's peers to derive any actionable benefits. When done correctly, Albireo Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Albireo Pharma.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Technology
Invested over 20 shares
Impulse
Invested over 200 shares
Investor Favorites
Invested few shares
Momentum
Invested over 60 shares
Please continue to Macroaxis Advice on Albireo Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Albireo Stock analysis

When running Albireo Pharma price analysis, check to measure Albireo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Albireo Pharma is operating at the current time. Most of Albireo Pharma's value examination focuses on studying past and present price action to predict the probability of Albireo Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Albireo Pharma's price. Additionally, you may evaluate how the addition of Albireo Pharma to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
The data published in Albireo Pharma's official financial statements usually reflect Albireo Pharma's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Albireo Pharma. For example, before you start analyzing numbers published by Albireo accountants, it's critical to develop an understanding of what Albireo Pharma's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Albireo Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Albireo Pharma's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Albireo Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Albireo Pharma. Please utilize our Beneish M Score to check the likelihood of Albireo Pharma's management to manipulate its earnings.